Barclays analyst Gena Wang maintained a Buy rating on 4D Molecular Therapeutics (FDMT – Research Report) today and set a price target of $45.00. The company’s shares closed last Friday at $5.97.

RBC Capital analyst Lisa Walter reiterated a Buy rating on 4D Molecular Therapeutics (FDMT – Research Report) today and set a price target of $39.00. The company’s shares opened today at $6.09.

After hours: February 12 at 5:20:12 PM EST Loading Chart for FDMT ...

After hours: February 13 at 4:01:06 PM EST Loading Chart for SIMO ...

Discover the Top 20 best Fashion Logos that define style in the industry! From iconic to innovative, explore how these logos captivate audiences! In fashion, logos are more than just symbols; they are ...